XML 25 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-Based Compensation
3 Months Ended
Apr. 27, 2024
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation

Note 11 – Share-Based Compensation

We have one equity incentive plan from which we are authorized to grant equity awards, the AstroNova, Inc. 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan provides for, among other things, the issuance of awards, including incentive stock options, non-qualified stock options, stock appreciation rights, time-based restricted stock units (“RSUs”), or performance-based restricted stock units (“PSUs”) and restricted stock awards (“RSAs”). At the June 6, 2023 annual meeting of shareholders, the 2018 Plan was amended to increase the number of shares of the Company’s common stock available for issuance by 600,000, bringing the total number of shares available for issuance under the 2018 Plan from 950,000 to 1,550,000. Under the 2018 Plan, we may also issue an additional number of shares equal to the number of shares subject to outstanding awards under our prior 2015 Equity Incentive Plan that are forfeited, canceled, satisfied without the issuance of stock, otherwise terminated (other than by exercise), or, for shares of stock issued pursuant to any unvested award, that are reacquired by us at not more than the grantee’s purchase price (other than by exercise). Under the 2018 Plan, all awards to employees generally have a minimum vesting period of one year. Options granted under the 2018 Plan must be issued at an exercise price of not less than the fair market value of our common stock on the date of grant and expire after ten years. Under the 2018 Plan, there were 80,780 unvested RSUs;164,234 unvested PSUs; and options to purchase an aggregate of 135,500 shares outstanding as of April 27, 2024.

In addition to the 2018 Plan, we previously granted equity awards under our 2015 Equity Incentive Plan (the “2015 Plan”) and our 2007 Equity Incentive Plan (the “2007 Plan”). No new awards may be issued under either the 2007 Plan or 2015 Plan, but outstanding awards will continue to be governed by those plans. As of April 27, 2024, options to purchase an aggregate of 241,649 shares were outstanding under the 2007 Plan and options to purchase an aggregate of 127,600 shares were outstanding under the 2015 Plan.

We also have a Non-Employee Director Annual Compensation Program (the “Program”) under which each non-employee director receives an automatic grant of RSAs on the date of the regular full meeting of the Board of Directors held each fiscal quarter. Under the Program, the number of whole shares to be granted each quarter is equal to 25% of the number calculated by dividing the director’s annual compensation amount, which is currently $70,000, by the fair market value of the Company’s stock on such day. All RSA’s granted under this Program vest immediately.

Share-based compensation expense was recognized as follows:

 

 

Three Months Ended

 

(In thousands)

 

April 27,
2024

 

 

April 29,
2023

 

Stock Options

 

$

 

 

$

 

Restricted Stock Awards and Restricted Stock Units

 

 

319

 

 

 

352

 

Employee Stock Purchase Plan

 

 

6

 

 

 

4

 

Total

 

$

325

 

 

$

356

 

 

Stock Options

Aggregated information regarding stock option activity for the three months ended April 27, 2024 is summarized below:

 

 

Number of
Options

 

 

Weighted Average
Exercise Price

 

Outstanding at January 31, 2024

 

 

523,349

 

 

$

15.26

 

Granted

 

 

 

 

 

 

Exercised

 

 

(10,900

)

 

 

14.18

 

Forfeited

 

 

(7,700

)

 

 

14.20

 

Canceled

 

 

 

 

 

 

Outstanding at April 27, 2024

 

 

504,749

 

 

$

15.30

 

 

 

Set forth below is a summary of options outstanding at April 27, 2024:

 

Outstanding

 

 

Exercisable

 

Range of
Exercise prices

 

Number
of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual Life

 

 

Number
of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted
Average
Remaining
Contractual Life

 

$10.01-15.00

 

 

293,274

 

 

$

13.75

 

 

 

1.9

 

 

 

293,274

 

 

$

13.75

 

 

 

1.9

 

$15.01-20.00

 

 

211,475

 

 

$

17.44

 

 

 

3.6

 

 

 

211,475

 

 

$

17.44

 

 

 

3.6

 

 

 

504,749

 

 

$

15.30

 

 

 

2.6

 

 

 

504,749

 

 

$

15.30

 

 

 

2.6

 

 

There were no stock options granted in fiscal 2024, or during the first three months of fiscal 2025, and as of April 27, 2024, there was no unrecognized compensation expense related to stock options.

Restricted Stock Units (RSUs), Performance-Based Stock Units (PSUs) and Restricted Stock Awards (RSAs)

Aggregated information regarding RSU, PSU and RSA activity for the three months ended April 27, 2024 is summarized below:

 

 

RSUs, PSUs & RSAs

 

 

Weighted Average
Grant Date Fair Value

 

Outstanding at January 31, 2024

 

 

300,705

 

 

$

12.90

 

Granted

 

 

26,387

 

 

 

17.85

 

Vested

 

 

(78,077

)

 

 

13.62

 

Forfeited

 

 

(4,001

)

 

 

12.81

 

Outstanding at April 27, 2024

 

 

245,014

 

 

$

13.20

 

 

As of April 27, 2024, there was approximately $2.1 million of unrecognized compensation expense related to RSUs, PSUs and RSAs, which is expected to be recognized over a weighted average period of 1.2 years.

Employee Stock Purchase Plan (ESPP)

Our ESPP allows eligible employees to purchase shares of common stock at a 15% discount from fair value on the first or last day of an offering period, whichever is less. A total of 40,000 shares were initially reserved for issuance under the ESPP. During the three months ended April 27, 2024, there were 2,246 shares purchased under the ESPP and there are 22,812 shares remaining available for purchase under the ESPP as of April 27, 2024.